Literature DB >> 33580876

Efficacy of Dietary Manipulations for Depleting Intrahepatic Triglyceride Content: Implications for the Management of Non-alcoholic Fatty Liver Disease.

Karoline Sandby1, Nina Rica Wium Geiker1, Maria Dalamaga2, Henning Grønbæk3, Faidon Magkos4.   

Abstract

PURPOSE OF REVIEW: Understanding the effects of dietary manipulations on intrahepatic triglyceride (IHTG) balance will have important implications for the prevention and treatment of non-alcoholic fatty liver disease (NAFLD). RECENT
FINDINGS: Reducing calorie intake to induce weight loss is the most potent intervention to decrease IHTG. Carbohydrate restriction during the initial stages of weight loss may be particularly beneficial, but at later stages, the amount of weight loss predominates over diet composition. By contrast, during weight stability, restricting calories from fat seems to be optimal for depleting liver fat. The degree of dietary fat saturation and the glycemic index of the carbohydrate have inconsistent effects on IHTG. Recently, the matrix of some foods (e.g., dairy) has been inversely associated with NAFLD. Dietary macronutrients differ in their effects on liver fat depending on the energy balance and the matrix of the food in which they are consumed. Therefore, investigations into dietary approaches for managing NAFLD should shift their perspective from that of isolated nutrients to that of whole foods and diets and include useful mechanistic insights.

Entities:  

Keywords:  Diet composition; Energy balance; Food matrix; Macronutrients; NAFLD; Weight loss

Year:  2021        PMID: 33580876     DOI: 10.1007/s13679-021-00430-4

Source DB:  PubMed          Journal:  Curr Obes Rep        ISSN: 2162-4968


  57 in total

1.  Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with Obesity.

Authors:  Faidon Magkos; Gemma Fraterrigo; Jun Yoshino; Courtney Luecking; Kyleigh Kirbach; Shannon C Kelly; Lisa de Las Fuentes; Songbing He; Adewole L Okunade; Bruce W Patterson; Samuel Klein
Journal:  Cell Metab       Date:  2016-02-22       Impact factor: 27.287

2.  Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.

Authors:  G Marchesini; M Brizi; G Bianchi; S Tomassetti; E Bugianesi; M Lenzi; A J McCullough; S Natale; G Forlani; N Melchionda
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

3.  Moderate Weight Loss Improves Body Composition and Metabolic Function in Metabolically Unhealthy Lean Subjects.

Authors:  Yu Chung Chooi; Cherlyn Ding; Zhiling Chan; John Choo; Suresh Anand Sadananthan; Navin Michael; Yijun Lee; S Sendhil Velan; Faidon Magkos
Journal:  Obesity (Silver Spring)       Date:  2018-04-19       Impact factor: 5.002

Review 4.  Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies.

Authors:  Norbert Stefan; Hans-Ulrich Häring; Kenneth Cusi
Journal:  Lancet Diabetes Endocrinol       Date:  2018-08-30       Impact factor: 32.069

5.  Regulation of glucose metabolism in nondiabetic, metabolically obese normal-weight Asians.

Authors:  Cherlyn Ding; Zhiling Chan; Yu Chung Chooi; John Choo; Suresh Anand Sadananthan; Amanda Chang; S Sasikala; Navin Michael; S Sendhil Velan; Faidon Magkos
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-01-02       Impact factor: 4.310

6.  Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity.

Authors:  Elisa Fabbrini; Faidon Magkos; B Selma Mohammed; Terri Pietka; Nada A Abumrad; Bruce W Patterson; Adewole Okunade; Samuel Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-24       Impact factor: 11.205

7.  Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction.

Authors:  Erik Kirk; Dominic N Reeds; Brian N Finck; S Mitra Mayurranjan; Mitra S Mayurranjan; Bruce W Patterson; Samuel Klein
Journal:  Gastroenterology       Date:  2009-01-25       Impact factor: 22.682

8.  Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis.

Authors:  Kittichai Promrat; David E Kleiner; Heather M Niemeier; Elizabeth Jackvony; Marie Kearns; Jack R Wands; Joseph L Fava; Rena R Wing
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

Review 9.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

Review 10.  The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).

Authors:  Elena Buzzetti; Massimo Pinzani; Emmanuel A Tsochatzis
Journal:  Metabolism       Date:  2016-01-04       Impact factor: 8.694

View more
  2 in total

1.  Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial.

Authors:  Mads N Thomsen; Mads J Skytte; Amirsalar Samkani; Martin H Carl; Philip Weber; Arne Astrup; Elizaveta Chabanova; Mogens Fenger; Jan Frystyk; Bolette Hartmann; Jens J Holst; Thomas M Larsen; Sten Madsbad; Faidon Magkos; Henrik S Thomsen; Steen B Haugaard; Thure Krarup
Journal:  Diabetologia       Date:  2022-01-07       Impact factor: 10.122

2.  Could gut mycobiome play a role in NAFLD pathogenesis? Insights and therapeutic perspectives.

Authors:  Dimitrios Fotis; Junli Liu; Maria Dalamaga
Journal:  Metabol Open       Date:  2022-03-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.